Author Correction: Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells - Methi Wathikthinnakon; Piriya Luangwattananun; Nunghathai Sawasdee; Chutipa Chiawpanit; Vannajan Sanghiran Lee; Piyarat Nimmanpipug; Yingmanee Tragoolpua; Siriphorn Rotarayanont; Thanich Sangsuwannukul; Nattaporn Phanthaphol; Yupanun Wutti‑in; Chalermchai Somboonpatarakun; et al. (Scientific Reports)